These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3261811)

  • 1. [Various cytokine-producing cells and target cells].
    Kobayashi Y
    Nihon Rinsho; 1988 May; 46(5):984-7. PubMed ID: 3261811
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytokines--DNA to immunologic diseases].
    Kishimoto T
    Nihon Rinsho; 1988 May; 46(5):981-3. PubMed ID: 3045371
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulator cells produce multiple nonantigen signals that determine T cell activation.
    Hwang LA; Boyle W
    Transplant Proc; 1989 Oct; 21(5):3755-6. PubMed ID: 2530674
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunology in internal medicine. 4. Cytokines and diseases].
    Miyasaka N
    Nihon Naika Gakkai Zasshi; 1988 Oct; 77(10):1506-9. PubMed ID: 3266637
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytokines and receptors--their functions, structures and cloning of code genes. Functional polymorphism of BSF-2/IL-6 and its abnormal expression].
    Hirano T; Taga T; Matsuda T; Horii Y; Tang B; Kawanishi Y; Suematsu S; Kishimoto T
    Nihon Rinsho; 1988 May; 46(5):1029-35. PubMed ID: 3261809
    [No Abstract]   [Full Text] [Related]  

  • 6. IL-6 is an intermediate in IL-1-induced thymocyte proliferation.
    Helle M; Boeije L; Aarden LA
    J Immunol; 1989 Jun; 142(12):4335-8. PubMed ID: 2786028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function.
    Parrish-Novak J; Dillon SR; Nelson A; Hammond A; Sprecher C; Gross JA; Johnston J; Madden K; Xu W; West J; Schrader S; Burkhead S; Heipel M; Brandt C; Kuijper JL; Kramer J; Conklin D; Presnell SR; Berry J; Shiota F; Bort S; Hambly K; Mudri S; Clegg C; Moore M; Grant FJ; Lofton-Day C; Gilbert T; Rayond F; Ching A; Yao L; Smith D; Webster P; Whitmore T; Maurer M; Kaushansky K; Holly RD; Foster D
    Nature; 2000 Nov; 408(6808):57-63. PubMed ID: 11081504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuously proliferating allospecific T cells, lifespan and antigen receptors.
    Dennert G; Raschke W
    Eur J Immunol; 1977 Jun; 7(6):352-9. PubMed ID: 70355
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential activation of cytokine genes in normal CD4-bearing T cells is stimulus dependent.
    Carding SR; West J; Woods A; Bottomly K
    Eur J Immunol; 1989 Feb; 19(2):231-8. PubMed ID: 2784764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity.
    Pouw N; Treffers-Westerlaken E; Mondino A; Lamers C; Debets R
    Mol Immunol; 2010 Apr; 47(7-8):1411-20. PubMed ID: 20303179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pleiotropic functions of BSF-2/IL-6].
    Matsuda T; Hirano T
    Tanpakushitsu Kakusan Koso; 1988 Jul; 33(8):1317-22. PubMed ID: 3265794
    [No Abstract]   [Full Text] [Related]  

  • 12. [B-lymphocyte hyperreactivity and differentiation factors of T-lymphocytes in systemic lupus erythematosus].
    Humbert M; Galanaud P
    Ann Med Interne (Paris); 1990; 141(3):213-6. PubMed ID: 2369009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway?
    Vignaux F; Golstein P
    Eur J Immunol; 1994 Apr; 24(4):923-7. PubMed ID: 7512034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the mitogenic and immune-modulating effects of plasminogen activator.
    Wainberg MA; Israel E; Margolese RG
    Immunology; 1982 Apr; 45(4):715-20. PubMed ID: 6978286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cytotoxicity of allosensitized T cells for autologous lymphoblastoid cell lines and human leukemia cells following propagation in T-cell growth factor.
    Zarling JM; Bach FH
    Transplant Proc; 1980 Mar; 12(1):164-6. PubMed ID: 6966097
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic Thy 1,2-positive blasts with NK-like target selectivity in murine mixed lymphocyte cultures.
    Kärre K; Seeley JK
    J Immunol; 1979 Oct; 123(4):1511-8. PubMed ID: 158052
    [No Abstract]   [Full Text] [Related]  

  • 18. Mouse IL-6. A hybridoma growth factor with multiple effects on normal B and T cells.
    Van Snick J; Renauld JC; Simpson RJ; Uyttenhove C; Vink A
    Ann N Y Acad Sci; 1989; 557():206-13, discussion 213-4. PubMed ID: 2786695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
    Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
    Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.